RESEARCH TRIANGLE PARK, N.C., March 22, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, and Richard I. Eisenstadt, Vice President and CFO, will present at the following upcoming investor conferences:
